Health effects of green tea catechins in overweight and obese men: A randomised controlled cross-over trial

British Journal of Nutrition

Volumn 106, Issue 12, 2011, Pages 1880-1889

  Brown, A L ^a   Lane, J ^a   Holyoak, C ^a   Nicol, B ^a   Mayes, A E ^a   Dadd, T ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

Blood pressure; Catechins; CVD; Obesity; Type 2 diabetes

Indexed keywords

CATECHIN; CATECHOL METHYLTRANSFERASE; CHOLESTEROL; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLUCOSE; GREEN TEA EXTRACT; INSULIN; METHIONINE; PLACEBO; TRIACYLGLYCEROL; VALINE;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BIOTRANSFORMATION; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG ACCUMULATION; GENOTYPE; HOMOZYGOSITY; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; TEA; UNSPECIFIED SIDE EFFECT; URINE LEVEL; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; AGED; ALLELES; BASE SEQUENCE; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CATECHIN; CATECHOL O-METHYLTRANSFERASE; CROSS-OVER STUDIES; DNA PRIMERS; DOUBLE-BLIND METHOD; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; TEA;

EID: 82555204534     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511002376     Document Type: Article

References (53)

1. Grassi D, Necozione S, Lippi C, et al. (2005) Flavanol-rich dark chocolate decreases blood pressure, improves endothelium-dependent vasorelaxation, and ameliorates insulin sensitivity in patients with essential hypertension. Hypertension 46, 890.
2. Grassi D, Desideri G, Necozione S, et al. (2008) Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 138, 1671-1676.
3. Taubert D, Roesen R, Lehmann C, et al. (2007) Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide-a randomized controlled trial. J Am Med Assoc 298, 49-60. (Pubitemid 47026770)
4. Engler MB, Engler MM, Chen CY, et al. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23, 197-204. (Pubitemid 38746107)
5. Schroeter H, Heiss C, Balzer J, et al. (2006) (2)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Nat Acad Sci 103, 1024-1029. (Pubitemid 43212215)
6. Loke WM, Hodgson JM, Proudfoot JM, et al. (2008) Pure dietary flavonoids quercetin and (2)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018-1025.
7. Moore RJ, Jackson KG & Minihane AM (2009) Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr 102, 1790-1802.
8. Henry JP & Stephenslarson P (1984) Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 6, 437-444. (Pubitemid 14091474)
9. Negishi H, Xu JW, Ikeda K, et al. (2004) Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 134, 38-42. (Pubitemid 38057420)
10. Potenza MA, Marasciulo FL, Tarquinio M, et al. (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292, E1378-E1387. (Pubitemid 46684607)
11. Yang YC, Lu FH, Wu JS, et al. (2004) The protective effect of habitual tea consumption on hypertension. Arch Intern Med 164, 1534-1540.
12. Brown AL, Lane J, Coverly J, et al. (2009) Effects of dietary supplementation with the green tea polyphenol epigalloca-techin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 101, 886-894.
13. Hodgson JM, Puddey IB, Burke V, et al. (1999) Effects on blood pressure of drinking green and black tea. J Hypertens 117, 457-463. (Pubitemid 29308554)
14. Hodgson JM, Puddey IB, Burke V, et al. (2006) Is reversal of endothelial dysfunction by tea related to flavonoid metabolism? Br J Nutr 95, 14-17. (Pubitemid 43250707)
15. Dawling S, Roodi N, Mernaugh RL, et al. (2001) Catechol-O- methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61, 6716-6722. (Pubitemid 32896493)
16. Syvanen AC, Tilgmann C, Rinne J, et al. (1997) Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 7, 65-71. (Pubitemid 27153321)
17. International Organization for Standardization (2005) ISO 14502-2: 2005. Determination of Substances Characteristic of Green and Black Tea-Part 2: Content of Catechins in Green Tea-Method Using High-Performance Liquid Chromatography. Geneva: ISO.
18. Khokhar S & Magnusdottir SGM (2002) Total phenol, cate-chin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50, 565-570. (Pubitemid 34106679)
19. Kuriyama S (2008) The relation between green tea consumption and cardiovascular disease as evidenced by epidemiolo-gical studies. J Nutr 138, 1548-1553.
20. Hodgson JM, Devine A, Puddey IB, et al. (2003) Tea intake is inversely related to blood pressure in older women. J Nutr 133, 2883-2886. (Pubitemid 37099776)
21. Stensvold I, Tverdal A, Solvoll K, et al. (1992) Tea consumption- relationship to cholesterol, blood-pressure, and coronary and total mortality. Prev Med 21, 546-553.
22. Abe Y, Umemura S, Sugimoto K, et al. (1995) Effect of green tea rich in g-aminobutyric-acid on blood-pressure of Dahl salt-sensitive rats. Am J Hypertens 8, 74-79.
23. Antonello M, Montemurro D, Bolognesi M, et al. (2006) Arterial benefits of green tea extract: anti-hypertension and prevention of cardiovascular damage and endothelial dysfunction in angiotensin II-dependent hypertension. Hypertension 48, 765-766.
24. Ikeda M, Suzuki C, Umegaki K, et al. (2007) Preventive effects of green tea catechins on spontaneous stroke in rats. Med Sci Monit 13, BR40-BR45. (Pubitemid 46238655)
25. Wu LY, Juan CC, Hwang LS, et al. (2004) Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr 43, 116-124. (Pubitemid 38661225)
26. Fukino Y, Ikeda A, Maruyama K, et al. (2007) Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 62, 953-960.
27. Nagao T, Hase T & Tokimitsu I (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 15, 1473-1483. (Pubitemid 47110911)
28. Frank J, George TW, Lodge JK, et al. (2009) Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk bio-markers in healthy men. J Nutr 139, 58-62.
29. Torok J (2008) Participation of nitric oxide in different models of experimental hypertension. Physiol Res 57, 813-825.
30. Lorenz M, Wessler S, Follmann E, et al. (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279, 6190-6195. (Pubitemid 38220652)
31. Persson IA, Josefsson M, Persson K, et al. (2006) Tea flava-nols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 58, 1139-1144. (Pubitemid 44213648)
32. Kim W, Jeong MH, Hong YJ, et al. (2006) The effect of green tea on endothelial dysfunction and circulating endothelial progenitor cells in the chronic smoker. Am J Cardiol 97, 60D.
33. Nagaya N, Yamamoto H, Uematsu M, et al. (2004) Green tea reverses endothelial dysfunction in healthy smokers. Heart 90, 1485-1486. (Pubitemid 39626337)
34. Widlansky ME, Hamburg NM, Anter E, et al. (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26, 95-102. (Pubitemid 46911252)
35. Murase T, Nagasawa A, Suzuki J, et al. (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes 26, 1459-1464. (Pubitemid 36005776)
36. Wu LY, Juan CC, Ho LT, et al. (2004) Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 52, 643-648.
37. Wolfram S, Raederstorff D, Preller M, et al. (2006) Epigalloca-techin gallate supplementation alleviates diabetes in rodents. J Nutr 136, 2512-2518. (Pubitemid 44521606)
38. Anderson RA & Polansky MM (2002) Tea enhances insulin activity. J Agric Food Chem 50, 7182-7186. (Pubitemid 35332804)
39. Broadhurst CL, Polansky MM & Anderson RA (2000) Insulinlike biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 48, 849-852. (Pubitemid 30194017)
40. Chen PC, Wheeler DS, Malhotra V, et al. (2002) A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 26, 233-241. (Pubitemid 34971887)
41. Pan MH, Lin-Shiau SY, Ho CT, et al. (2000) Suppression of lipopolysaccharide-induced nuclear factor-kB activity by theaflavin-3,3- digallate from black tea and other polyphe-nols through down-regulation of IkB kinase activity in macrophages. Biochem Pharmacol 59, 357-367.
42. Yang FJ, Oz HS, Barve S, et al. (2001) The green tea polyphe-nol (-)-epigallocatechin-3-gallate blocks nuclear factor-kB activation by inhibiting IkB kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 60, 528-533. (Pubitemid 32781560)
43. Shoelson SE, Lee J & Yuan M (2003) Inflammation and the IKKb/IkB/NF-kB axis in obesity-and diet-induced insulin resistance. Int J Obes 27, S49-S52. (Pubitemid 38019189)
44. Anton S, Melville L & Rena G (2007) Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 19, 378-383. (Pubitemid 44969987)
45. Fukino Y, Shimbo M, Aoki N, et al. (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol 51, 335-342. (Pubitemid 41727426)
46. Ryu OH, Lee J, Lee KW, et al. (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Prac 71, 356-358.
47. Venables MC, Hulston CJ, Cox HR, et al. (2008) Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 87, 778-784. (Pubitemid 351364561)
48. Hursel R, Viechtbauer W & Westerterp-Plantenga MS (2009) The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes 33, 956-961.
49. Murase T, Misawa K, Haramizu S, et al. (2009) Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 78, 78-84.
50. Chen D, Wang CY, Lambert JD, et al. (2005) Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol 69, 1523-1531. (Pubitemid 40602453)
51. Wolfram S, Wang Y & Thielecke F (2006) Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 50, 176-187. (Pubitemid 43325659)
52. Wu AH, Tseng CC, Van den Berg D, et al. (2003) Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 63, 7526-7529. (Pubitemid 37413498)
53. Sermswan A, Uboldejpracharak Y, Suthichaiyakul T, et al. (2002) Blood pressure response to antihypertensive agents related to baseline blood pressure. J Med Assoc Thai 85, 1113-1120. (Pubitemid 36134970)